Two key patent cases that no doubt will impact the future of personalized medicine are pending review by the US Supreme Court. What will the Court decide?
The Scientist
Most Recent
Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.
Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.
A lot changes in a child’s body over the course of development, and not all changes occur linearly: gene expression can fluctuate, and organs can perform different functions on the way to their final purpose in the body. Here are some of the key deve
When children need medications, getting the dosing and method of administration right is like trying to hit a moving target with an untried weapon.
Immune cells in skin provide powerful protection against infection, suggesting new routes for vaccination.
How to successfully surmount the challenges women face in becoming biotech industry leaders
Turning a standard technique into an unbiased screen for diagnostic biomarkers
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
